Nanomedicine is a promising strategy for improving clinical outcomes for cancer therapies,
by improving drug efficacy through enhanced delivery to disease sites. It is of importance for …

The recent emergence of nanomedicine has revolutionized the therapeutic landscape and
necessitated the creation of more sophisticated drug delivery systems. Polymeric …

Covalent PEGylation of biologics has been widely employed to reduce immunogenicity,
while improving stability and half-life in vivo. This approach requires covalent protein …

Highlights•Nanocarriers with the ability to target tumors are being increasingly explored.•
Nanomedicine aid in maintaining a balance between efficacy and toxicity.•Recent advances …

Dexrazoxane (DXZ) reduces cytotoxicity caused by Doxorubicin (DOX). However, the
mechanism of DXZ in ferroptosis and cardiomyopathy remains unclear. This research …

Hyperbranched polymers (HBPs) have found use in a wide range of applications, such as
optical, electronic and magnetic materials, coatings, additives, supramolecular chemistry …

Paclitaxel (PTX) and docetaxel (DTX) are key members of taxanes with high anti-tumor
activity against various cancer cells. These chemotherapeutic agents suffer from a number of …

The high incidence rates of prostate cancer (PCa) raise demand for improved therapeutic
strategies. Prostate tumors specifically express the prostate‐specific membrane antigen …

Malignant tumors are characterized by structural and molecular peculiarities providing a
possibility to directionally deliver antitumor drugs with minimal impact on healthy tissues and …

Theranostic biomaterials have been creating great new opportunities in developing
precision medicine in cancer treatment. Moreover, there exist up-coming potentials to find a …